About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Pfizer: Breaking Up Is Hard to Do | Main | A Look Inside the Compound Collections »

May 2, 2011

Great Moments in Journal Editing

Email This Entry

Posted by Derek

I don't know if this DOI link resolves yet - or if the problem will be fixed by the time it does. But for now, in the "Articles in Press" queue over at Drug Discovery Today, they have one whose title reads like this:

Utility of protein structures in overcoming ADMET-related issues of drug-like compounds[1. AU: You use ADMET-relevant throughout manuscript. Would you like to change this to ADMET-relevant too?]

Well, would you? They're waiting for someone to answer them, apparently.

Comments (10) + TrackBacks (0) | Category: The Scientific Literature


1. Hap on May 2, 2011 2:28 PM writes...

I vote yes.

Permalink to Comment

2. HappyDog on May 2, 2011 2:52 PM writes...

I vote no. Just because the issues are related to ADMET doesn't necessarily mean that they are relevant to ADMET. Therefore, changing related to relevant could change the original intent of the author's meaning.

On the other hand, we could do an experiment to see how well people swallow 'relevant' versus 'related' (absorption?), or see if the difference between the two sinks in to the central nervous system (blood-brain barrier penetration), whether the knowledge is internalized (distributed), digested (metabolized), rejected (excretion), or just makes the reader vomit (toxicity).

Permalink to Comment

3. TFox on May 2, 2011 2:57 PM writes...

There are a number of other queries to the authors in the PDF too. The one in the title is the most amusing, though, especially if someone were to follow literally the journal's recommendation for citing the article in press:

"Please cite this article as: Stoll, F., Göller, A.H., Hillisch, A., Utility of protein structures in overcoming ADMET-related issues of drug-like compounds[1. AU: You use ADMET-relevant throughout manuscript. Would you like to change this to ADMET- relevant too?], Drug Discovery Today (2010), doi:10.1016/j.drudis.2011.04.008"

Permalink to Comment

4. Hap on May 2, 2011 2:59 PM writes...

But if "relevant" isn't what the author(s) meant, then why use it elsewhere in the manuscript?

The alternative, which might be better, would be to change the term to "ADMET-related issues" everywhere. I just would prefer the document to be consistent in using whatever term it's using.

Permalink to Comment

5. Neil on May 3, 2011 5:32 AM writes...

The article is listed as 'article in press', which if you click through using the handy 'Note to users' you can see that articles in press may be "Uncorrected proofs: these are copy edited and formatted articles that are not yet finalized and that will be corrected by the authors. Therefore the text could change before final publication."

Sorry to spoil the fun.

Permalink to Comment

6. scieditor on May 3, 2011 7:56 AM writes...

Ah, the perils of editing in the digital age. It used to be that authors could just ignore our queries. Now, everyone knows they ignored our queries.

Permalink to Comment

7. andrewD on May 3, 2011 8:49 AM writes...

scieditor @6
You knew it would be one of those days didn't you!
There is a typo in the URL attached to your name ("," in stead of">")

Permalink to Comment

8. andrewD on May 3, 2011 8:53 AM writes...

and that will teach me not to preview , "." not">"
i shouldn't have tried to be funny

Permalink to Comment

9. MLBpitcher_and_MedicinalChemist on May 3, 2011 9:19 AM writes...

You got arrested fora DUI Derek:

Permalink to Comment

10. Anonymous on May 3, 2011 11:36 AM writes...

This is all irrelated.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry